DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY.

摘要

The present invention relates to compositions comprising drospirenone together with a pharmaceutically acceptable carrier of excipient, wherein said composition does not contain an estrogen. In one embodiment drospirenone is in micronized form. In another embodiment drospirenone is in a form having a surface area of more than 10,000 cm 2 /g. In a further embodiment drospirenone is in a form having rapid dissolution such that at least 70% of said drospirenone is dissolved within 30 minutes when the composition is subjected to dissolution testing in 900 ml of water at 37 °C using USP XXIII Paddle Method II operated at a stirring rate of 50 rpm. In a still further embodiment the composition comprises inert carrier particles containing drospirenone on their surface.